Browse Category

Investment Analysis News 3 December 2025

Exxon Mobil (XOM) Stock Today: UBS $145 Target, West Qurna Talks and 2026 Oil Glut Fears – December 3, 2025 Update

Exxon Mobil (XOM) Stock Today: UBS $145 Target, West Qurna Talks and 2026 Oil Glut Fears – December 3, 2025 Update

Exxon Mobil Corporation (NYSE: XOM) has entered December 2025 near the top of its 52‑week range, with fresh “Buy” ratings, a higher dividend, and a set of headline‑grabbing strategic moves that stretch from Texas to Iraq and Guyana. At the same time, Wall Street is warning that crude prices could be materially lower by 2026, putting the focus squarely on which oil majors can thrive in a mid‑cycle pricing world. As of intraday trading on December 3, 2025, Exxon Mobil stock is changing hands around $117.9 per share, up roughly 2.2% on the day, giving the company a market capitalization
AppLovin (APP) Stock Jumps on AI Adtech Momentum Despite SEC Probe – Latest News & Forecasts as of December 3, 2025

AppLovin (APP) Stock Jumps on AI Adtech Momentum Despite SEC Probe – Latest News & Forecasts as of December 3, 2025

AppLovin Corporation (NASDAQ: APP) is back in rally mode. As of Wednesday, December 3, 2025, the stock is trading in the mid‑$660s, up roughly 1–2% on the day and near recent highs after a powerful rebound from its October pullback.StockAnalysis Fueled by explosive growth in its AI‑driven Axon 2.0 advertising engine and fresh bullish analyst calls, APP is one of 2025’s standout tech winners — but the story is complicated by an ongoing SEC probe into its data‑collection practices and heavy insider selling. Below is a detailed look at today’s key news, forecasts, and analysis around AppLovin stock, curated from
CoreWeave (CRWV) Stock After a 45% November Crash: Latest News, Analyst Forecasts and AI Cloud Outlook as of December 3, 2025

CoreWeave (CRWV) Stock After a 45% November Crash: Latest News, Analyst Forecasts and AI Cloud Outlook as of December 3, 2025

CoreWeave, Inc. (NASDAQ: CRWV) has become one of the most closely watched AI infrastructure stocks in 2025. After a spectacular run following its March IPO, the Nvidia‑backed GPU cloud provider is now grappling with a brutal drawdown, mounting debt, and growing debate over whether its valuation still makes sense. As of late trading on December 3, 2025, CoreWeave shares trade around the mid‑$70s (roughly $77, up about 1–2% on the day), well above the $40 IPO price but roughly 60% below their late‑June peak near $187. Yahoo Finance+1 Below is a detailed, SEO‑focused look at CoreWeave stock today – including
Boeing (BA) Stock Today: Spirit AeroSystems Ruling, Cash-Flow Pledge and Airbus Troubles Move the Share Price – December 3, 2025

Boeing (BA) Stock Today: Spirit AeroSystems Ruling, Cash-Flow Pledge and Airbus Troubles Move the Share Price – December 3, 2025

Boeing Company (The) stock is back in the spotlight after a dramatic 10% surge on Tuesday and a fresh wave of regulatory and analyst headlines on December 3, 2025. Between a conditional green light for the Spirit AeroSystems takeover, upbeat cash‑flow guidance from the new CFO, and new problems at rival Airbus, investors are rapidly repricing Boeing’s long‑running turnaround story. Barron’s+3Reuters+3Reuters+3 Below is a detailed, Google‑News‑friendly rundown of today’s news, forecasts, and analysis impacting Boeing (BA) stock. 1. How Boeing Stock Is Trading on December 3, 2025 After soaring 10.15% on December 2 to a close of $205.38, Boeing shares
Pure Storage (PSTG) Stock Plunges After Q3 Earnings: What December’s Sell-Off Means for the AI Storage Leader

Pure Storage (PSTG) Stock Plunges After Q3 Earnings: What December’s Sell-Off Means for the AI Storage Leader

As of December 3, 2025, Pure Storage, Inc. (NYSE: PSTG) has gone from AI darling to one of the day’s biggest losers on Wall Street. After reporting strong third-quarter fiscal 2026 results, the all-flash data storage specialist saw its stock price collapse by roughly 26% to about $70, cutting deeply into gains that had left it near a 52‑week high above $100 earlier this week. StockAnalysis+1 Despite the violent reaction, the company’s fundamentals and analyst forecasts tell a more nuanced story—one that’s less about collapsing demand and more about valuation, margins, and the cost of chasing AI hyperscaler growth. What
C3.ai Stock (AI) on December 3, 2025: Earnings Day, Microsoft Tie-Up and Sale Rumors Put the Spotlight Back on This Volatile AI Name

C3.ai Stock (AI) on December 3, 2025: Earnings Day, Microsoft Tie-Up and Sale Rumors Put the Spotlight Back on This Volatile AI Name

C3.ai, Inc. (NYSE: AI) is back in the headlines today as the enterprise AI software company prepares to report fiscal Q2 2026 earnings after the closing bell. The stock has been crushed in 2025, is flirting with “special situation” territory, and yet sits at the center of some of the biggest themes in tech: generative AI, cloud partnerships, and a possible company sale. TipRanks+1 Below is a structured look at where C3.ai stands right now—its latest stock performance, Wall Street forecasts, technical picture, the new CEO, Microsoft partnership expansion, and what tonight’s earnings could mean next. Where C3.ai Stock Trades
Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook

Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook

Updated December 3, 2025 Capricor Therapeutics, Inc. (NASDAQ: CAPR) has just turned into one of the wildest biotech stories of 2025. After the company reported positive topline results from its pivotal Phase 3 HOPE‑3 trial of deramiocel in Duchenne muscular dystrophy (DMD) early Wednesday, CAPR stock exploded from roughly $6.36 at Tuesday’s close to around $30 in Wednesday’s trading — a move of about +380%, with intraday highs near $40 and gains at one point exceeding +500%. BioPharma Dive At the same time, Wall Street analysts, regulators and patient advocates are rapidly reassessing both the approval odds and the long‑term
Regeneron Pharmaceuticals (REGN) Stock Outlook: Morgan Stanley Downgrade, Eylea HD Win and Gene‑Editing Push – December 3, 2025Regeneron

Regeneron Pharmaceuticals (REGN) Stock Outlook: Morgan Stanley Downgrade, Eylea HD Win and Gene‑Editing Push – December 3, 2025Regeneron

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is ending 2025 in full “complex biotech” mode: the share price has rebounded, the dividend is now real, a flagship drug just got a powerful new label, a rare-disease medicine crushed a Phase 3 trial, and Wall Street is suddenly a bit less euphoric about the stock. On December 3, Morgan Stanley cut Regeneron from Overweight to Equal Weight with a $767 price target, arguing that the shares now more or less reflect fair value and that future upside will depend on how clearly the company can execute on its pipeline. MarketScreener+1 At the same
IREN Limited (IREN) Stock on 3 December 2025: Capital Raise, AI Cloud Supercycle and What Analysts Expect Next

IREN Limited (IREN) Stock on 3 December 2025: Capital Raise, AI Cloud Supercycle and What Analysts Expect Next

IREN Limited (NASDAQ: IREN) — the former Bitcoin miner now repositioned as an AI data‑center and cloud infrastructure player — is back in the spotlight on 3 December 2025 after unveiling a massive capital raise to fund its Microsoft AI deal and refinance older debt. At the same time, Wall Street’s forecasts for IREN point to big upside and big execution risk. Below is a detailed, SEO‑optimized rundown of the latest IREN stock news, forecasts, and analysis as of December 3, 2025. This article is for information only and is not financial advice. IREN stock today: price, performance and volatility
Intel (INTC) Stock Surges on Apple Chip Rumors and $208M Malaysia Expansion: 2025 Rally, Analyst Forecasts and What’s Next

Intel (INTC) Stock Surges on Apple Chip Rumors and $208M Malaysia Expansion: 2025 Rally, Analyst Forecasts and What’s Next

Updated December 3, 2025 – This article is for informational purposes only and is not investment advice. Intel Stock Today: Price, Performance and Valuation Intel Corporation (NASDAQ: INTC) is back in the spotlight. As of December 3, 2025, Intel shares trade around $43.47, essentially flat on the day but hovering at fresh 52‑week highs near $43.68, with a market cap of roughly $208 billion. MarketBeat That’s an astonishing turnaround from the stock’s 52‑week low near $17.67, meaning the share price has more than doubled from its 2024 nadir. MarketBeat+1 Depending on the data source and whether you include dividends, Intel’s
Strategy Inc (MSTR) Stock on December 3, 2025: MSCI Index Threat, $1.44 Billion Cash Reserve and Bitcoin Slump – What It All Means

Strategy Inc (MSTR) Stock on December 3, 2025: MSCI Index Threat, $1.44 Billion Cash Reserve and Bitcoin Slump – What It All Means

Strategy Inc (NASDAQ: MSTR), the company formerly known as MicroStrategy, remains the purest listed proxy for Bitcoin – and right now, that makes it one of the most controversial stocks on Wall Street. As of midday on December 3, 2025, MSTR trades around $182 per share, down roughly 37% year to date and more than 60% below its 52‑week high near $457, even after a modest rebound.Finviz+1 Despite the drawdown, the company commands a market capitalization of about $52 billion, trades near book value (~$182 per share), and carries a trailing P/E of about 8.5 with a very high beta
Salesforce (CRM) Stock Today: Q3 2026 Earnings Preview, AI Agentforce Bet and Analyst Forecasts (Dec. 3, 2025)

Salesforce (CRM) Stock Today: Q3 2026 Earnings Preview, AI Agentforce Bet and Analyst Forecasts (Dec. 3, 2025)

Salesforce, Inc. (NYSE: CRM) heads into a high‑stakes earnings night on Wednesday, December 3, 2025, with its stock trading around $235–236 per share, up modestly intraday but still deeply in the red for 2025.MarketBeat After a year in which the shares have fallen roughly 30% year to date and become one of the weakest performers in the Dow, several major Wall Street firms and independent analysts are suddenly calling Salesforce “historically cheap” heading into its third‑quarter fiscal 2026 (Q3 FY26) earnings release after the closing bell.Yahoo Finance+1 At the same time, management is talking up a “record year” and a
1 220 221 222 223 224 282

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop